Bayer HealthCare
The Pharmaceuticals Division generally procures the raw materials for manufacturing
the active ingredients of its prescription medicines from external suppliers.
We hold strategic reserves to prevent supply bottlenecks and possible
dependence on suppliers. We mitigate major price fluctuations by purchasing
the intermediates required to manufacture our principal active ingredients
from several suppliers on the basis of global contracts. The active ingredients
of our prescription medicines are currently manufactured almost entirely
in Wuppertal, Germany, for Bayer production facilities worldwide. Our
most important pharmaceutical production plants are located in Leverkusen,
Germany; Berkeley, California, United States; Garbagnate and Rosia,
Italy; and Shiga, Japan. Our products are primarily distributed through
wholesalers, pharmacies and hospitals.
Since we actively compete with other drug suppliers worldwide, we seek
to reinforce our external distribution network with co-promotion and
co-marketing arrangements. In September 2004 we entered into a strategic
alliance with
Schering-Plough under which that company distributes our primary care
products in the United States. At the same time, we market cancer drugs
from Schering-Plough in selected countries. Bayer and Schering-Plough
also plan to jointly market Schering-Plough’s product Zetia® in
Japan, where it is currently involved in the registration process. In
October 2005 we signed a strategic cooperation agreement with Johnson & Johnson
under the terms of which Johnson & Johnson is supporting the development
of our antithrombotic drug
BAY 59-7939. It is intended that Johnson & Johnson market the newly
developed drug in the United States at a later date. Furthermore, Bayer
and Johnson & Johnson will jointly market Johnson & Johnson’s
urology drug Elmiron® in the United States.
The activities of our Consumer Care Division are focused
on over-the-counter medicines that patients can generally
purchase without a prescription. Consumer Care procures
extensive volumes of certain raw materials from within
the Bayer Group. The most important raw materials that
we buy in bulk from third parties are ascorbic acid,
citric acid, paracetamol, sodium citrate and tartaric
acid. These are generally readily available. To minimize
business risks, we diversify our raw material procurement
sources worldwide and conclude long-term supply agreements.
The division’s sales and distribution channels
outside Europe are typically supermarket chains, drugstores
and other wholesalers. In Europe, pharmacies are the
primary distribution channel.
The Diagnostics Division manufactures or assembles
most of its products itself. We operate a supplier
management process and procure raw materials, components
and finished products on an OEM (original equipment
manufacturer) basis. The materials we purchase directly
are generally not subject to significant fluctuations
in price or availability. Our diagnostic systems are
marketed directly to reference laboratories, private
laboratories and hospitals, as well as through a network
of distribution companies.
The sole production facility in the Diabetes Care
Division is located in Mishawaka, Indiana, United States.
About one third of products are manufactured or assembled
directly by Bayer, while the rest are procured from
OEM suppliers. The delivery of raw materials, components
and finished products is based on a supplier management
process. Access to most of the materials is thus safeguarded
through contractual agreements, and they are therefore
not subject to major fluctuations in price or availability.
Delivery bottlenecks for some direct or OEM materials
would have negative consequences for the earnings performance
of Diabetes Care. These items include customer-specific,
integrated circuits and sensors for producing the
Ascensia® blood glucose measurement system. We
therefore hold strategic reserves of certain direct
materials or finished products in order to be able
to supply our customers consistently and reliably.
Furthermore, we maintain a global supplier network.
Our Diabetes Care products are marketed to consumers
through distribution companies and large drugstore
and retail chains.
The Animal Health Division procures pharmaceutical
ingredients for its veterinary medicines both from
within the Bayer Group and from external suppliers
throughout the world. Depending on local regulatory
frameworks, animal health products may be available
to end users over the counter or with a prescription
issued by a veterinarian.
Bayer CropScience
Crop Protection procures most of its raw materials from external companies.
The cost of some raw materials depends on fluctuating oil and energy
prices and freight charges. As most of our sales are generated in the
northern hemisphere, the business depends especially on the growing
seasons for the relevant crops and the respective distribution cycles.
The products of Crop Protection are marketed either to wholesalers
or directly to retailers through a two- or three-tier distribution
system, according to local market conditions.
Our Environmental Science Business Group markets its
products to both professional users and amateur gardeners
through various distribution channels. Our green industry,
pest control and barn hygiene products are marketed
directly to professional users, while home and garden
products are sold through specialist dealers.
BioScience makes its seed products available to end
users, distributors and processing industries. Traits
developed using plant biotechnology are either outlicensed
to other seed companies for use in their products or
sold through our own seed companies. Important brands
here include InVigor® and FiberMax®. In some
cases we make plant traits available to other companies
for use in their own research and products.
Bayer MaterialScience
The Polycarbonates business unit of Bayer
MaterialScience sells its products primarily to injection molding and
extrusion processors for the manufacture of plastics components used
predominantly in the automotive, electronics, construction, data systems,
medical equipment and leisure sectors. The key petrochemical raw materials
used by our Polycarbonates business unit are acetone and phenol. With
raw material costs affected mainly by the volatility of oil and benzene
prices, we generally conclude long-term supply agreements containing
cost-based and market-price-oriented adjustment formulas. Our products
are marketed chiefly through regional distribution channels. We also
use trading houses and sell to smaller customers through local distributors.
The activities of Wolff Walsrode focus on building
materials, industrial coatings, printing inks for soft
packaging, and the health care market. In Germany and
the United States, Wolff Walsrode normally sells its
cellulose products directly. Elsewhere, products are
marketed through Bayer’s global sales organization.
The principal raw material for our cellulose derivatives
is chemical-grade cellulose produced from raw cellulose
and cotton. We regard our procurement risk for this
material as low.
H.C. Starck supplies materials and components for
the electronics, optics, aviation, aerospace and medical
technology industries. As we operate our own tungsten
recycling facilities, we are only partially dependent
on Chinese imports. The supply of raw materials is
covered by long-term agreements which mostly run for
three to five years. H.C. Starck maintains its own
international sales organizations and liaison offices
worldwide. This subsidiary also makes use of other
sales organizations that are responsible for maintaining
direct contact with customers. For example, Ampere® products
are jointly marketed with Dutch-based Flame Spray Technologies.
The polyurethane products of the Polyurethanes business
unit, which are based on isocyanate-
polyol systems, are used in the automotive, construction,
electronics and furniture industries and in leisure
articles. The primary raw materials are petrochemical
feedstocks, which we mostly procure on the open market
through long-term agreements. A global joint venture
with Lyondell provides a supply source for propylene
oxide, one of our most important raw materials. These
petrochemical feedstocks are subject to price fluctuations
on the crude oil and derivatives markets. We mostly
sell our isocyanate and polyol products directly to
customers. Europe, the NAFTA countries and Asia are
the primary markets for our polyurethanes business,
with the Asian market continuing to show the highest
growth rates.
Our Coatings, Adhesives, Sealants business unit is
a leading manufacturer of raw materials for coatings
and adhesives used primarily in the automotive, furniture,
plastics and construction industries. Temporary fluctuations
in prices for oil or utilities, for example, can heavily
impact the cost of our raw materials. For this reason,
supplies of the principal chemical raw materials are
secured through long-term agreements. Bulk customers
with global operations are serviced directly by our
key account managers. |